At the Intersection: Jacob and Eli Berlin on How Terray Merges Chemistry and Compute to Drive Drug Discovery
About this episode
Jacob and Eli Berlin discuss how Terray is transforming drug discovery through the integration of chemistry and AI.
Working at the intersection of chemistry, machine learning, and AI, Jacob and Eli Berlin discuss how Terray is transforming drug discovery. By building and testing small molecules at a massive scale, Terray accelerates candidate discovery in uncharted chemical space and redefines what an AI-native biotech can achieve.
People in this episode
Guests: Jacob Berlin, Eli Berlin
Topics covered
- drug discovery
- machine learning
- chemistry
- AI
- biotechnology
Keywords
- drug discovery
- machine learning
- AI
- chemistry
- biotech
Mentioned in this episode
Organizations: Terray, AI-native biotech
More episodes of The Future of Healthcare AI
- Spanning Every Surface: Google Cloud’s Aashima Gupta on AI, Access, and Adaptive Healthcare
- Medicare meets AI: Andrew Toy on How Clover Health Superpowers Clinicians and Enables Earlier Intervention
- Where Pharma Wins: Jaswinder Chadha on How Axtria Uses AI to Drive Commercial Ops and Outcomes
- Operationalizing AI: Aman Wasan on How the ArisGlobal Digital Platform Powers Safer, Smarter Therapies
- The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery
- How AI Turns Data into Discovery
Explore listener stats, chart rankings, contacts and more on the The Future of Healthcare AI podcast page.